NasdaqCM - Nasdaq Real Time Price USD

Aclarion, Inc. (ACON)

7.70

+0.19

+(2.53%)

At close: 4:00:01 PM EDT

7.70

0.00

(0.00%)

After hours: 4:27:42 PM EDT

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

BROOMFIELD, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 12:30 PM ET. Brent Ness, Chief Executive Officer of Aclarion, wil

GlobeNewswire 11 hours ago

ACON
+2.53%
ACONW
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative DiscographyConclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% BROOMFIELD, Colo., April 21, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of

GlobeNewswire 2 days ago

ACON
+2.53%
ACONW
Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025BROOMFIELD, Colo., April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on We

GlobeNewswire 14 days ago

ACON
+2.53%
ACONW
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan p

GlobeNewswire 21 days ago

ACON
+2.53%
ACONW
Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully funded with initial interim results expected in Q2 2026 BROOMFIELD, Colo., March 31, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprieta

GlobeNewswire 23 days ago

ACON
+2.53%
ACONW
Aclarion Announces Reverse Stock Split

BROOMFIELD, Colo., March 26, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that effective before market open on Friday March 28, 2025, it will complete a 1-for-27 reverse stock split of its common stock. On September 23, 2024, the Company’s stockholders app

GlobeNewswire 28 days ago

ACON
+2.53%
ACONW
Aclarion Provides Shareholder Update

BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it has issued an 8k filing that provides an update for stakeholders to review. The filing can be viewed here. The Company intends on filing its 10K by the end of March and

GlobeNewswire last month

ACON
+2.53%
ACONW
Aclarion announces expansion plans with RadNet affiliates in NY, NJ

Aclarion (ACON) announced plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan sites with RadNet (RDNT) affiliates in both states and are driven by the increased availability of MR Spectroscopy and enhanced remote operations capabilities within RadNet to meet growing market demand for Nociscan. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See I

TipRanks last month

ACON
+2.53%
ACONW

RDNT
Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Lenox Hill Radiology (LHR) in New York and New Jersey Imaging Network (NJIN) to add Nociscan across multiple sitesBROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today plans to expand Nociscan access across key markets in New York

GlobeNewswire last month

ACON
+2.53%
ACONW
Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?

Aclarion, Inc. (NASDAQ:ACON) shares are trading higher premarket on Monday after the company disclosed a commercial partnership with Scripps Health in San Diego, CA. This agreement will introduce Nociscan to Southern California and to the top spine specialists at Scripps Green and Scripps Health. Notably, Scripps Health is a nonprofit healthcare system that operates five hospitals and 19 outpatient facilities, serving half a million patients annually with the support of 2,600 affiliated physicia

Benzinga last month

ACONW
Aclarion Announces First Commercial Agreement with Scripps Health

Agreement expands access to Nociscan technology for leading spine physicians and more than 3.2M people in the greater San Diego Metro area Nociscan leverages MR Spectroscopy (MRS) and Augmented Intelligence (AI) to Identify Sources of Chronic Low Back Pain BROOMFIELD, Colo., March 03, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to

GlobeNewswire last month

ACON
+2.53%
ACONW
Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned to Wednesday, March 5, 2025 at 9:30 a.m. Mountain TimeBROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced that its Special Meeting of Stockholders (the “Special Meeting”) scheduled for Feb

GlobeNewswire last month

ACON
+2.53%
ACONW
Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit

We recently compiled a list of the Top 8 Must-See AI News Updates Investors Probably Missed. In this article, we are going to take a look at where Aclarion, Inc. (NASDAQ:ACON) stands against the other AI stocks. As the US and Asia, led by China, continue to make staggering advancements in AI, experts worry that Europe […]

Insider Monkey 2 months ago

ACONW
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Dr. Nicholas Theodore to highlight NOCISCAN capabilities combining MR Spectroscopy and augmented intelligence (AI) NOCISCAN is an innovative decision support tool that helps physicians personalize treatment for chronic low back pain BROOMFIELD, Colo., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify

GlobeNewswire 2 months ago

ACON
+2.53%
ACONW
Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Recent Notice of Allowance is for Aclarion’s 24th issued US patent Propionic acid (PA) is a biomarker the literature suggests may be indicative of bacterial infection and pain in an intervertebral disc Patent will expand Aclarion’s proprietary rights to use MRS to measure propionic acid as a biomarker for the identification of potential infection and pain throughout the body BROOMFIELD, Colo., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),

GlobeNewswire 2 months ago

ACON
+2.53%
ACONW
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while reducing costs for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),

GlobeNewswire 2 months ago

ACON
+2.53%
ACONW
Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference

We recently compiled a list of the 12 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at where Aclarion, Inc. (NASDAQ:ACON) stands against the other AI stocks investors shouldn’t miss. As artificial intelligence continues to evolve, investors are closely watching the opportunities emerging in both private […]

Insider Monkey 2 months ago

ACONW
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trial CLARITY is a prospective, randomized, multicenter study to validate Nociscan’s ability to improve surgical outcomes Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, A

GlobeNewswire 2 months ago

ACON
+2.53%
ACONW
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain BROOMFIELD, Colo., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced

GlobeNewswire 2 months ago

ACON
+2.53%
ACONW
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market

BROOMFIELD, CO - January 30, 2025 (NEWMEDIAWIRE) - Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physi...

NewMediaWire 2 months ago

ACON
+2.53%
ACONW

Performance Overview

Return	ACON	S&P 500 (^GSPC)
YTD	-99.41%	-8.60%
1-Year	-99.70%	+6.02%
3-Year	-100.00%	+25.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Aclarion, Inc. (ACON)

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Aclarion Announces Reverse Stock Split

Aclarion Provides Shareholder Update

Aclarion announces expansion plans with RadNet affiliates in NY, NJ

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?

Aclarion Announces First Commercial Agreement with Scripps Health

Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference

Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market

Performance Overview